GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hansa Biopharma AB (OSTO:HNSA) » Definitions » Price-to-Tangible-Book

Hansa Biopharma AB (OSTO:HNSA) Price-to-Tangible-Book : (As of Jun. 12, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Hansa Biopharma AB Price-to-Tangible-Book?

As of today (2024-06-12), Hansa Biopharma AB's share price is kr53.15. Hansa Biopharma AB's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was kr-9.91. Hence, Hansa Biopharma AB's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Hansa Biopharma AB's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Hansa Biopharma AB's highest Price to Tangible Book Ratio was 365.09. The lowest was 4.49. And the median was 9.21.

OSTO:HNSA's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.795
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Hansa Biopharma AB's share price is kr53.15. Hansa Biopharma AB's Book Value per Sharefor the quarter that ended in Mar. 2024 was kr-7.11. Hence, Hansa Biopharma AB's P/B Ratio of today is .


Hansa Biopharma AB Price-to-Tangible-Book Historical Data

The historical data trend for Hansa Biopharma AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansa Biopharma AB Price-to-Tangible-Book Chart

Hansa Biopharma AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.34 8.83 5.42 4.64 -

Hansa Biopharma AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.85 26.42 - - -

Competitive Comparison of Hansa Biopharma AB's Price-to-Tangible-Book

For the Biotechnology subindustry, Hansa Biopharma AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hansa Biopharma AB's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hansa Biopharma AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Hansa Biopharma AB's Price-to-Tangible-Book falls into.



Hansa Biopharma AB Price-to-Tangible-Book Calculation

Hansa Biopharma AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=53.15/-9.905
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Hansa Biopharma AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Hansa Biopharma AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Hansa Biopharma AB (OSTO:HNSA) Business Description

Traded in Other Exchanges
Address
Scheelevagen 22, Lund, SWE, 223 63
Hansa Biopharma AB is a biopharmaceutical company that develops immunomodulatory treatments for enabling transplantations and rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection, and cancer. The company's product candidate, imlifidase, is an antibody-cleaving enzyme being developed to enable kidney transplantation in sensitized patients and further developed for use in other organ and tissue transplantation as well as acute autoimmune indications. It operates in Sweden, other European countries, and the U.S. The group generates the majority of its revenue from product sales.

Hansa Biopharma AB (OSTO:HNSA) Headlines

No Headlines